At SupplySide Global 2026, 5 speakers from ingredient suppliers discussed protein, fiber, botanicals, and peptides for consumers using or leaving GLP-1 medications.
|Articles|April 17, 2013
SupplySide Marketplace Preview: PhosphoLean NOPE+EGCG
PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets.
Advertisement
PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets. PhosphoLean signals the brain to switch off the sensations of hunger and helps individuals manage their stressful diets and lower diet depression. PhosphoLean can be a keynote ingredient for a company’s next weight-management product.
Booth 138
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What Japan's Red Yeast Rice Crisis Teaches Ingredient Suppliers About FDA's New NDI Guidance
2
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
3
SupplySide Global Panelists Outline Product Opportunities Tied to GLP-1 Medication Use
4
Vitaquest's 2027 Consumer Trends Forecast
5